[1]
|
W. L. Jorgensen, “The Many Roles of Computation in Drug Discovery,” Science, Vol. 303, No. 5665, 2004, pp. 1813-1818. doi:10.1126/science.1096361
|
[2]
|
O. Guvench and A. D. MacKerell, “Computational Evaluation of Protein-Small Molecule Binding,” Current Opinion in Structural Biology, Vol. 19, No. 1, 2009, pp. 56-61. doi:10.1016/j.sbi.2008.11.009
|
[3]
|
M. K. Gilson and H.-X. Zhou, “Calculation of Protein-Ligand Binding Affinities,” Annual Review of Biophysics and Biomolecular Structure, Vol. 36, 2007, pp. 21-42. doi:10.1146/annurev.biophys.36.040306.132550
|
[4]
|
M. R. Shirts, D. L. Mobley and J. D. Chodera, “Alchemical Free Energy Calculations: Ready for Prime Time?” Annual Reports in Computational Chemistry, Vol. 3, 2007, pp. 41-59. doi:10.1016/S1574-1400(07)03004-6
|
[5]
|
D. L. Mobley and K. A. Dil, “Binding of Small-Molecule Ligands to Proteins: ‘What You See’ Is Not Always ‘What You Get’,” Structure, Vol. 17, No. 4, 2009, pp. 489-498.
|
[6]
|
Y. Q. Deng and B. Roux, “Computations of Standard Binding Free Energies with Molecular Dynamics Simulations,” The Journal of Physical Chemistry B, Vol. 113, No. 8, 2009, pp. 2234-2246. doi:10.1021/jp807701h
|
[7]
|
J. D. Chodera, D. L. Mobley, M. R. Shirts, R. W. Dixon, K. Branson and V. S. Pande, “Alchemical Free Energy Methods for Drug Discovery: Progress and Challenges,” Current Opinion in Structural Biology, Vol. 21, No. 2, 2011, pp. 150-160.
|
[8]
|
E. Perola and P. S. Charifson, “Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding,” Journal of Medicinal Chemistry, Vol. 47, No. 10, 2004, pp. 2499-2510. doi:10.1021/jm030563w
|
[9]
|
J. Liebeschuetz, J. Hennemann, T. Olsson and C. Groom, “The Good, the Bad and the Twisted: A Survey of Ligand Geometry in Protein Crystal Structures,” Journal of Computer-Aided Molecular Design, Vol. 26, No. 2, 2012, pp. 169-183.
|
[10]
|
M. Lapelosa, E. Gallicchio, G. F. Arnold, E. Arnold and R. M. Levy, “In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 GP41 Epitopes,” Journal of Molecular Biology, Vol. 385, No. 2, 2009, pp. 675-691.
doi:10.1016/j.jmb.2008.10.089
|
[11]
|
M. Lapelosa, G. F. Arnold, E. Gallicchio, E. Arnold and R. M. Levy, “Antigenic Characteristics of Rhinovirus Chimeras Designed in Silico for Enhanced Presentation of HIV-1 GP41 Epitopes,” Journal of Molecular Biology, Vol. 397, No. 3, 2010, pp. 752-766.
doi:10.1016/j.jmb.2010.01.064
|
[12]
|
J. E. DeLorbe, J. H. Clements, M. G. Teresk, A. P. Benfield, H. R. Plake, L. E. Millspaugh and S. F. Martin, “Thermodynamic and Structural Effects of Conformational Constraints in Protein-Ligand Interactions. Entropic Paradoxy Associated with Ligand Preorganization,” Journal of the American Chemical Society, Vol. 131, No. 46, 2009, pp. 16758-16770.
doi:10.1021/ja904698q
|
[13]
|
M. Bizzarri, S. Marsili and P. Procacci, “Intraligand Hydrophobic Interactions Rationalize Drug Affinities for Peptidyl-Prolyl Cis-Trans Isomerase Protein,” The Journal of Physical Chemistry B, Vol. 115, No. 19, 2011, pp. 6193-6201. doi:10.1021/jp110585p
|
[14]
|
M. Bizzarri, E. Tenori, M. R. Martina, S. Marsili, G. Caminati, S. Menichetti and P. Procacci, “New Perspective on How and Why Immunophilin fk506-Related Ligands Work,” The Journal of Physical Chemistry Letters, Vol. 2, No. 22, 2011, pp. 2834-2839.
doi:10.1021/jz201037u
|
[15]
|
C.-Y. Yang, H. Y. Sun, J. Y. Chen, Z. Nikolovska-Coleska and S. M. Wang, “Importance of Ligand Reorganization Free Energy in Protein-Ligand Binding-Affinity Prediction,” Journal of the American Chemical Society, Vol. 131, No. 38, 2009, pp. 13709-13721.
doi:10.1021/ja9039373
|
[16]
|
C. Gao, M.-S. Park and H. A. Stern, “Accounting for Ligand Conformational Restriction in Calculations of Protein-Ligand Binding Affinities,” Biophysical Journal, Vol. 98, No. 5, 2010, pp. 901-910.
doi:10.1016/j.bpj.2009.11.018
|
[17]
|
K. Andries, H. Azijn, T. Thielemans, D. Ludovici, M. Kukla, J. Heeres, P. Janssen, B. De Corte, J. Vingerhoets, R. Pauwels and M.-P. de Bthune, “Tmc125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active Against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1,” Antimicrobial Agents and Chemotherapy, Vol. 48, No. 12, 2004, pp. 4680-4686.
doi:10.1128/AAC.48.12.4680-4686.2004
|
[18]
|
P. A. J. Janssen, P. J. Lewi, E. Arnold, F. Daeyaert, M. de Jonge, J. Heeres, L. Koymans, M. Vinkers, J. Guillemont, E. Pasquier, M. Kukla, D. Ludovici, K. Andries, M.-P. de Bèthune, R. Pawels, K. Das, A. D. Clark Jr., Y. V. Frenkel, S. H. Hughes, B. Medaer, F. De Knaep, H. Bohets, F. De Clerck, A. Lampo, P. Williams and P. Stoffels, “In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1e)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitri
|
[19]
|
K. Das, A. D. Clark, P. J. Lewi, J. Heeres, M. R. De Jonge, L. M. H. Koymans, H. M. Vinkers, F. Daeyaert, D. W. Ludovici, M. J. Kukla, B. De Corte, R. W. Kavash, C. Y. Ho, H. Ye, M. A. Lichtenstein, K. Andries, R. Pauwels, M.-P. De Bthune, P. L. Boyer, P. Clark, S. H. Hughes, P. A. J. Janssen and E. Arnold, “Roles of Conformational and Positional Adaptability in Structure-Based Design of Tmc125-r165335 (Etravirine) and Related Non-Nucleo0 side Reverse Transcriptase Inhibitors That Are Highly Potent and Effe
|
[20]
|
K. Das, P. J. Lewi, S. H. Hughes and E. Arnold, “Crystallography and the Design of Anti-AIDS Drugs: Conformational Flexibility and Positional Adaptability Are Important in the Design of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors,” Progress in Biophysics and Molecular Biology, Vol. 88, No. 2, 2005, pp. 209-231. doi:10.1016/j.pbiomolbio.2004.07.001
|
[21]
|
K. Das, J. D. Bauman, A. D. Clark, Y. V. Frenkel, P. J. Lewi, A. J. Shatkin, S. H. Hughes and E. Arnold, “High-Resolution Structures of HIV-1 Reverse Transcriptase/tmc278 Complexes: Strategic Flexibility Explains Potency against Resistance Mutations,” Proceedings of the National Academy of Sciences, Vol. 105, No. 5, 2008, pp. 1466-1471. doi:10.1073/pnas.0711209105
|
[22]
|
Y. V. Frenkel, A. D. Clark, K. Das, Y.-H. Wang, P. J. Lewi, P. A. J. Janssen and E. Arnold, “Concentration and pH Dependent Aggregation of Hydrophobic Drug Molecules and Relevance to Oral Bioavailability,” Journal of Medicinal Chemistry, Vol. 48, No. 6, 2005, pp. 1974-1983. doi:10.1021/jm049439i
|
[23]
|
Y. V. Frenkel, E. Gallicchio, K. Das, R. M. Levy and E. Arnold, “Molecular Dynamics Study of Non-Nucleoside Reverse Transcriptase Inhibitor 4-[[4-[[4-[(e)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (Tmc278/Rilpivirine) Aggregates: Correlation between Amphiphilic Properties of the Drug and Oral Bioavailability,” Journal of Medicinal Chemistry, Vol. 52, No. 19, 2009, pp. 5896-5905.
doi:10.1021/jm900282z
|
[24]
|
H. Okumura, E. Gallicchio and R. M. Levy, “Conformational Populations of Ligand-Sized Molecules by Replica Exchange Molecular Dynamics and Temperature Reweighting,” Journal of Computational Chemistry, Vol. 31, 2010, pp. 1357-1367.
|
[25]
|
Y. Frenkel, “The Roles of Structural Variability and Amphiphilicity of TMC278/Rilpivirine in Mechanisms of HIV Drug Resistance Avoidance and Enhanced Oral Bioavailability,” PhD thesis, Rutgers University, Piscataway, 2009.
|
[26]
|
E. Gallicchio and R. M. Levy, “Advances in All Atom Sampling Methods for Modeling Protein-Ligand Binding Affinities,” Current Opinion in Structural Biology, Vol. 21, No. 2, 2011, pp. 161-166.
doi:10.1016/j.sbi.2011.01.010
|
[27]
|
D. L. Mobley, “Let’s Get Honest about Sampling,” Journal of Computer-Aided Molecular Design, Vol. 26, No. 1, 2012, pp. 93-95. doi:10.1007/s10822-011-9497-y
|
[28]
|
M. Lapelosa, E. Gallicchio and R. M. Levy, “Conformational Transitions and Convergence of Absolute Binding Free Energy Calculations,” Journal of Chemical Theory and Computation, Vol. 8, 2012, pp. 47-60.
doi:10.1021/ct200684b
|
[29]
|
E. Gallicchio and R. M. Levy, “Prediction of Sample Host-Guest Affinities with the Binding Energy Distribution Analysis Method (BEDAM),” Journal of Computer-Aided Molecular Design, 2012, in Press.
doi:10.1007/s10822-012-9552-3
|
[30]
|
E. Gallicchio, M. Lapelosa and R. M. Levy, “Binding Energy Distribution Analysis Method (BEDAM) for Estimation of Protein-Ligand Binding Affinities,” Journal of Chemical Theory and Computation, Vol. 6, No. 9, 2010, pp. 2961-2977. doi:10.1021/ct1002913
|
[31]
|
D. L. Mobley, J. D. Chodera and K. A. Dill, “On the Use of Orientational Restraints and Symmetry Corrections in Alchemical Free Energy Calculations,” Journal of Chemical Physics, Vol. 125, No. 8, 2006, Article ID: 084902. doi:10.1063/1.2221683
|
[32]
|
D. L. Mobley, J. D. Chodera and K. A. Dill, “The Confine-and-Release Method: Obtaining Correct Binding Free Energies in the Presence of Protein Conformational Change,” Journal of Chemical Theory and Computation, Vol. 3, No. 4, 2007, pp. 1231-1235.
doi:10.1021/ct700032n
|
[33]
|
E. B. Lansdon, K. M. Brendza, M. Hung, R. Wang, S. Mukund, D. Jin, G. Birkus, N. Kutty and X. H. Liu, “Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design,” Journal of Medicinal Chemistry, Vol. 53, No. 10, 2010, pp. 4295-4299.
doi:10.1021/jm1002233
|
[34]
|
M. K. Gilson, J. A. Given, B. L. Bush and J. A. McCammon, “The Statistical-Thermodynamic Basis for Computation of Binding Affinities: A Critical Review,” Biophysical Journal, Vol. 72, 1997, pp. 1047-1069.
doi:10.1016/S0006-3495(97)78756-3
|
[35]
|
F. P. Buelens and H. Grubmüller, “Linear-Scaling Soft-Core Scheme for Alchemical Free Energy Calculations,” Journal of Computational Chemistry, Vol. 33, No. 1, 2012, pp. 25-33. doi:10.1002/jcc.21938
|
[36]
|
M. R. Shirts and J. D. Chodera, “Statistically Optimal Analysis of Samples from Multiple Equilibrium States,” Journal of Chemical Physics, Vol. 129, No. 12, 2008, Article ID: 124105. doi:10.1063/1.2978177
|
[37]
|
E. Gallicchio and R. M. Levy, “Advances in Protein Chemistry and Structural Biology,” Recent Theoretical and Computational Advances for Modeling Protein-Ligand Binding Affinities, Academic Press, London, Vol. 85, 2011, pp. 27-80.
|
[38]
|
E. Gallicchio and R. M. Levy, “AGBNP: An Analytic Implicit Solvent Model Suitable for Molecular Dynamics Simulations and High-Resolution Modeling,” Journal of Computational Chemistry, Vol. 25, 2004, pp. 479-499.
doi:10.1002/jcc.10400
|
[39]
|
E. Gallicchio, K. Paris and R. M. Levy, “The AGBNP2 Implicit Solvation Model,” Journal of Chemical Theory and Computation, Vol. 5, No. 9, 2009, pp. 2544-2564.
doi:10.1021/ct900234u
|
[40]
|
W. L. Jorgensen, D. S. Maxwell and J. Tirado-Rives, “Developement and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids,” Journal of the American Chemical Society, Vol. 118, 1996, pp. 11225-11236.
doi:10.1021/ja9621760
|
[41]
|
G. A. Kaminski, R. A. Friesner, J. Tirado-Rives and W. L. Jorgensen, “Evaluation and Reparameterization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides.” The Journal of Physical Chemistry B, Vol. 105, 2001, pp. 6474-6487. doi:10.1021/jp003919d
|
[42]
|
J. L. Banks, J. S. Beard, Y. Cao, A. E. Cho, W. Damm, R. Farid, A. K. Felts, T. A. Halgren, D. T. Mainz, J. R. Maple, R. Murphy, D. M. Philipp, M. P. Repasky, L. Y. Zhang, B. J. Berne, R. A. Friesner, E. Gallicchio and R. M. Levy, “Integrated Modeling Program, Applied Chemical Theory (IMPACT),” Journal of Computational Chemistry, Vol. 26, 2005, pp. 1752-1780.
doi:10.1002/jcc.20292
|
[43]
|
R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter and E. De Clercq, “Rapid and Automated Tetrazolium-Based Colorimetric Assay for the Detection of Anti-HIV Compounds,” Journal of Virological Methods, Vol. 20, No. 4, 1988, pp. 309-321.
doi:10.1016/0166-0934(88)90134-6
|
[44]
|
M. Mihailescu and M. K. Gilson, “On the Theory of Noncovalent Binding,” Biophysical Journal, Vol. 87, No. 1, 2004, pp. 23-36. doi:10.1529/biophysj.103.031682
|
[45]
|
J. Kim and J. E. Straub, “Generalized Simulated Tempering for Exploring Strong Phase Transitions,” Journal of Chemical Physics, Vol. 133, No. 15, 2010, Article ID: 154101. doi:10.1063/1.3503503
|
[46]
|
D. H. Min, M. Chen, L. Q. Zheng, Y. H. Jin, M. A. Schwartz, Q.-X. A. Sang and W. Yang, “Enhancing qm/mm Molecular Dynamics Sampling in Explicit Environments via an Orthogonal-Space-Random-Walk-Based Strategy,” The Journal of Physical Chemistry B, Vol. 115, No. 14, 2011, pp. 3924-3935. doi:10.1021/jp109454q
|
[47]
|
C. A. Chang, W. Chen and M. K. Gilson, “Ligand Configurational Entropy and Protein Binding,” Proceedings of the National Academy of Sciences, Vol. 104, No. 5, 2007, pp. 1534-1539. doi:10.1073/pnas.0610494104
|